Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Risk factors for preeclampsia in healthy nulliparous women.

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women,

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women,

Authors:

Location:

Go back to Resources

Risk factors for mortality in infants and young children on dialysis: A report of the North American Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Risk factors for mortality in infants and young children on dialysis: A report of the North American Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Report on the standardization of clonogeneic hematopoietic precursor assays for the NHLBI Unrelated Donor Bone Marrow Transplantation Trial,

Go back to Resources

Report on the standardization of clonogeneic hematopoietic precursor assays for the NHLBI Unrelated Donor Bone Marrow Transplantation Trial,

Authors:

Go back to Resources

Report on the Standardization of Clonogeneic Hematopoietic Precursor Assays for the NHLBI Unrelated Donor Bone Marrow Transplant Trial,

Go back to Resources

Report on the Standardization of Clonogeneic Hematopoietic Precursor Assays for the NHLBI Unrelated Donor Bone Marrow Transplant Trial,

Authors:

Location:

Go back to Resources

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents.

Go back to Resources

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Renal transplantation in children with sickle cell disease: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Renal transplantation in children with sickle cell disease: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Renal transplantation in children from 1987-1996: The Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Renal transplantation in children from 1987-1996: The Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Realistic power simulations compare point- and area-based disease cluster tests,

Go back to Resources

Realistic power simulations compare point- and area-based disease cluster tests,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Quality of life in cancer chemotherapy trials: review of study characteristics.

Go back to Resources

Quality of life in cancer chemotherapy trials: review of study characteristics.

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 105
  • Page 106
  • Page 107
  • Page 108
  • Current page 109
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions